Filing Details
- Accession Number:
- 0001209191-18-046308
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-08-10 18:36:35
- Reporting Period:
- 2018-08-09
- Accepted Time:
- 2018-08-10 18:36:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1326732 | Xencor Inc | XNCR | Pharmaceutical Preparations (2834) | 201622502 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1591313 | R John Desjarlais | C/O Xencor, Inc. 111 West Lemon Avenue Monrovia CA 91016 | Sr. V.p., Research & Cso | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-08-09 | 35,000 | $4.25 | 123,098 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-08-09 | 20,133 | $40.61 | 102,965 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-08-10 | 14,867 | $40.03 | 88,098 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2018-08-09 | 35,000 | $0.00 | 35,000 | $4.25 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 27,522 | 2023-09-03 | No | 4 | M | Direct |
Footnotes
- Includes the following shares acquired by the Reporting Person pursuant to the Issuer's Employee Stock Purchase Plan: 156 shares of Common Stock acquired on June 19, 2017, 159 shares of Common Stock acquired on December 10, 2017 and 107 shares of Common Stock acquired on June 8, 2018.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.77 to $42.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.0558, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- The stock option is fully vested and exercisable.
Billionaire Hedge Funds
